Načítá se...
Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
OBJECTIVES: Adjunctive host-directed therapy is emerging as a new potential approach to improve the outcome of conventional antimicrobial treatment for tuberculosis (TB). We tested the ability of a phosphodiesterase-4 inhibitor (PDE4i) CC-11050, co-administered with the first-line anti-TB drug isoni...
Uloženo v:
Vydáno v: | EBioMedicine |
---|---|
Hlavní autoři: | , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Elsevier
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4776074/ https://ncbi.nlm.nih.gov/pubmed/26981575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.01.015 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|